ReviewNatural product reports2026
Inverse stable isotopic labeling for natural product characterization and discovery.
Review in Natural product reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Covering: 2005 to 2026Stable isotopic labeling is a powerful tool in natural products research; however, the isotopically substituted precursors required for conventional labeling approaches are not always available. In such cases, inverse stable isotopic labeling (InverSIL) offers an effective alternative. In this approach, natural product producing organisms are grown on isotopically substituted media, which is then supplemented with precursors at their natural isotopic abundance. Incorporation of these unlabeled precursors can be readily detected due to their isotopic contrast, circumventing limitations associated with precursor availability. Here, we review applications of InverSIL in the characterization of natural product biosynthetic pathways and structures, as well as its use in genome mining to link biosynthetic genes to the natural products they produce. We also discuss contexts in which the InverSIL approach is particularly advantageous, as well as situations where its utility may be limited. Through this review, we aim to encourage broader adoption of InverSIL as a versatile strategy for advancing natural products research.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.